Stock CANF CAN-FITE BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Can-Fite BioPharma Ltd.

Equities

CANF

IL0010944739

Delayed TEL AVIV STOCK EXCHANGE
Other stock markets
 08:57:46 21/05/2024 BST 		5-day change 1st Jan Change
2.9 ILa 0.00% Intraday chart for Can-Fite BioPharma Ltd. +7.41% +11.54%
05-12 Transcript : Can-Fite BioPharma Ltd. - Special Call
05-09 Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Can-Fite Biopharma Price Target to $18 From $34, Maintains Buy Rating
MT
CAN FITE BIOPHARMA : Aegis Capital Starts Can-Fite Biopharma at Buy with $5 Price Target
MT
DJ Industrial : Wall Street Narrowly Mixed; Data, Fed Rate Meeting in Focus
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CANF Stock
  4. News Can-Fite BioPharma Ltd.
  5. Analyst Reco.